Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | CDC25A | P30304 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphocholine SCHEMBL14742788 | 1.00 | LPAR3 (0.46) | LPAR3LPAR1LPAR2SMN1; SMN2ADRA1A | |
| Phosphocholine SCHEMBL8012 | 1.00 | LPAR3 (0.46) | LPAR3LPAR1LPAR2SMN1; SMN2ADRA1A | |
| Phosphocholine SCHEMBL30504754 | 0.98 | LPAR3 (0.45) | LPAR3LPAR1LPAR2SMN1; SMN2ADRA1A | |
| Phosphocholine SCHEMBL30576387 | 0.98 | LPAR3 (0.45) | LPAR3LPAR1LPAR2SMN1; SMN2ADRA1A | |
| Phosphocholine SCHEMBL28883972 | 0.98 | LPAR3 (0.45) | LPAR3LPAR1LPAR2SMN1; SMN2ADRA1A | |
| Phosphocholine SCHEMBL8584620 | 0.98 | CHRM5 (0.46) | LPAR3LPAR1LPAR2SMN1; SMN2ADRA1A | |
| Phosphocholine SCHEMBL24426 | 0.98 | CHRM5 (0.46) | LPAR3LPAR1LPAR2SMN1; SMN2ADRA1A | |
| Phosphocholine SCHEMBL17373733 | 0.98 | LPAR3 (0.45) | LPAR3LPAR1LPAR2SMN1; SMN2ADRA1A | |
| Phosphocholine SCHEMBL10935529 | 0.98 | LPAR3 (0.45) | LPAR3LPAR1LPAR2SMN1; SMN2ADRA1A | |
| Phosphocholine SCHEMBL31388514 | 0.98 | LPAR3 (0.45) | LPAR3LPAR1LPAR2SMN1; SMN2ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130178653-A1 | NOVEL PRECURSOR OF RADIOLABELLED CHOLINE ANALOG COMPOUNDS | IMPERIAL COLLEGE (GB) | 2013-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178653-A1 | NOVEL PRECURSOR OF RADIOLABELLED CHOLINE ANALOG COMPOUNDS | CHAT, CEPT1, SLC5A7 | LPAR3 235/4885LPAR1 356/4885LPAR2 788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.